Double-blind, Placebocontrolled A Randomized Trial on the Efficacy of Herbal Galactogogues
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02233439 |
Recruitment Status : Unknown
Verified September 2014 by Antonella Cromi, Università degli Studi dell'Insubria.
Recruitment status was: Not yet recruiting
First Posted : September 8, 2014
Last Update Posted : September 8, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Breastfeeding | Dietary Supplement: Herbal galactagogue Dietary Supplement: Placebo | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 210 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Triple (Participant, Care Provider, Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Efficacy of Herbal Galactogogues: a Double-blinded, Placebo-controlled Randomized Trial. |
Study Start Date : | September 2014 |
Estimated Primary Completion Date : | January 2015 |
Estimated Study Completion Date : | March 2015 |

Arm | Intervention/treatment |
---|---|
Placebo Comparator: Placebo
a placebo identical in appearance to the galactagogue product
|
Dietary Supplement: Placebo |
No Intervention: No treatment
Usual care and breastfeeding support
|
|
Experimental: Herbal galactagogue
A commercially available product containing a combination of Silybum marianum 400 mg and Galega officinalis 150 mg, once a day for 6 weeks
|
Dietary Supplement: Herbal galactagogue
Other Name: Piùlatte® Plus (MILTE ITALIA SpA) |
- Percentage of mothers who exclusively breastfeed their child [ Time Frame: At 6 weeks postpartum ]
- Rate of breastfeeding (either exclusively or as a supplement to formula feeding ) [ Time Frame: at 6 weeks and 3 months ]
- Volume (mL) and frequency (times a day) of formula [ Time Frame: 6 weeks postpartum ]
- weight gain experienced by the newborns [ Time Frame: 6 weeks postpartum ]
- serum prolactin level [ Time Frame: at baseline and 6 weeks after treatment ]
- Rate of maternal allergic reactions and gastrointestinal side effects [ Time Frame: 6 weeks postpartum ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- singleton, term delivery
- >2.5 kg newborn weight
- lactation-deficiency
Exclusion Criteria:
- Neonatal Intensive Care Unit admission
- use of galactagogue drugs
- allergy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02233439
Contact: Antonella Cromi, MD | antonella.cromi@uninsubria.it |
Italy | |
Azienda Ospedaliero-Universitaria Ospedale di Circolo e Fondazione Macchi, Presidio F. Del Ponte | |
Varese, Italy, 21100 | |
Principal Investigator: Antonella Cromi, MD |
Responsible Party: | Antonella Cromi, Associate professor, Università degli Studi dell'Insubria |
ClinicalTrials.gov Identifier: | NCT02233439 |
Other Study ID Numbers: |
IRB 54/2013 |
First Posted: | September 8, 2014 Key Record Dates |
Last Update Posted: | September 8, 2014 |
Last Verified: | September 2014 |
galactagogues herbs breastfeeding |
supplements Silybum marianum Galega officinalis |
Galactogogues Physiological Effects of Drugs |